Clinical trials
Completed Critical Illness trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
342 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 7 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 11 |
| 2009 | 6 |
| 2010 | 10 |
| 2011 | 11 |
| 2012 | 9 |
| 2013 | 14 |
| 2014 | 21 |
| 2015 | 13 |
| 2016 | 21 |
| 2017 | 21 |
| 2018 | 29 |
| 2019 | 27 |
| 2020 | 24 |
| 2021 | 24 |
| 2022 | 24 |
| 2023 | 22 |
| 2024 | 19 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 342 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 12 |
| Mayo Clinic | 7 |
| B. Braun Melsungen AG | 6 |
| Medical University of Vienna | 6 |
| University of Pennsylvania | 6 |
| University of Pittsburgh | 6 |
| Vanderbilt University | 6 |
| Charite University, Berlin, Germany | 5 |
| Columbia University | 5 |
| Vanderbilt University Medical Center | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Critical Illness | 342 |
| Sepsis | 21 |
| Delirium | 16 |
| Anxiety Disorders | 15 |
| Hyperglycemia | 15 |
| Insulin Resistance | 15 |
| Respiratory Insufficiency | 12 |
| COVID-19 | 11 |
| Muscle Weakness | 10 |
| Muscular Atrophy | 10 |
Trials
Showing 1 to 25 of 342. Each trial links to its page on Pharma Observatory.
242 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.